{"database": "lobbying", "table": "lobbying_activities", "rows": [[2468350, "5b550962-4f81-4c53-9ec9-1d8f6a56d127", "Q2", "SUMMIT PUBLIC AFFAIRS", 401105467, "VANDA PHARMACEUTICALS INC.", 2020, "second_quarter", "PHA", "Issues affecting the pharmaceutical industry, including the prescription drug approval process, animal testing, and gastroparesis issues.\nAdministration of the 21st Century Cares Act (Pub. L. No. 114-255).\nAdministration of the Coronavirus Aid, Relief, and Economic Security (CARES) Act (Pub. L. No. 116-136).\nCOVID-19 Clinical Trials.\nAgriculture, Rural Development, FDA, and Related Agencies Appropriations for FY2021, provisions regarding FDA testing for new drug applications.", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2020-07-16T12:41:24.497000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2468350"], "units": {}, "query_ms": 1.5708180144429207, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}